Crystal structure of (E)-2-((3-fluoropyridin-4-yl) methylene)-7-methoxy-3,4-dihydronaphthalen1(2H)-one, C17H14FNO2

被引:4
作者
Wang, Chen [1 ]
Wang, Lei [1 ]
Meng, Qing-Guo [2 ]
Huang, Zhi-Xin [1 ]
Ma, Nuan-Nuan [1 ]
Wang, Chun-Hua [1 ]
机构
[1] Binzhou Med Univ, Sch Pharm, Key Lab Prescript Effect & Clin Evaluat, State Adm Tradit Chinese Med China, Yantai 264003, Peoples R China
[2] Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Key Lab Mol Pharmacol & Drug Evaluat, Sch Pharm,Minist Educ, Yantai 264005, Peoples R China
来源
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2021年 / 236卷 / 05期
关键词
LIPOPHILICITY; DERIVATIVES; DESIGN;
D O I
10.1515/ncrs-2021-0223
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
C17H14FNO2, monoclinic, P2(1)/n (no. 14), a = 8.0937(8) angstrom, b = 7.1326(6) angstrom, c = 22.367(2) A, beta = 90.863(9)degrees, V = 1291.1(2) angstrom(3), Z = 4, R-gt(F) = 0.0404, wR(ref) (F-2) = 0.0974, T = 99.97(16) K.
引用
收藏
页码:1073 / 1075
页数:3
相关论文
共 19 条
[1]  
Amakali Klaudia T., 2018, Central Nervous System Agents in Medicinal Chemistry, V18, P136, DOI 10.2174/1871524918666180501121638
[2]   Benzylidenetetralones, cyclic chalcone analogues, induce cell cycle arrest and apoptosis in HCT116 colorectal cancer cells [J].
Drutovic, David ;
Chripkova, Martina ;
Pilatova, Martina ;
Kruzliak, Peter ;
Perjesi, Pal ;
Sarissky, Marek ;
Lupi, Monica ;
Damia, Giovanna ;
Broggini, Massimo ;
Mojzis, Jan .
TUMOR BIOLOGY, 2014, 35 (10) :9967-9975
[3]   Crystal structure of (E)-2-(4-hydroxy-3-methoxybenzylidene)-6-methoxy-3,4-dihydronaphthalen-1(2H)-one, C19H18O4 [J].
El-Sayed, Nahed N. E. ;
Almaneai, Norah M. ;
Ghabbour, Hazem A. ;
Alafeefy, Ahmed M. .
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2017, 232 (02) :203-205
[4]   Design, Synthesis, and Evaluation of (2-(Pyridinyl)methyIene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity [J].
Gibson, Maya Z. ;
Nguyen, Minh A. ;
Zingales, Sarah K. .
MEDICINAL CHEMISTRY, 2018, 14 (04) :333-343
[5]   Chalcone derivatives as potential antifungal agents: Synthesis, and antifungal activity [J].
Gupta, Deepa ;
Jain, D. K. .
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2015, 6 (03) :114-117
[6]   Characterization of lipophilicity and antiproliferative activity of E-2-arylmethylene-1-tetralones and their heteroanalogues [J].
Hallgas, B ;
Dobos, Z ;
Osz, E ;
Hollósy, F ;
Schwab, RE ;
Szabó, EZ ;
Eros, D ;
Idei, M ;
Kéri, G ;
Lóránd, T .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 819 (02) :283-291
[7]   Metabolic and Pharmaceutical Aspects of Fluorinated Compounds [J].
Johnson, Benjamin M. ;
Shu, Yue-Zhong ;
Zhuo, Xiaoliang ;
Meanwell, Nicholas A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (12) :6315-6386
[8]   Introduction of amino moiety enhances the inhibitory potency of 1-tetralone chalcone derivatives against LPS-stimulated reactive oxygen species production in RAW 264.7 macrophages [J].
Katila, Pramila ;
Shrestha, Aastha ;
Shrestha, Aarajana ;
Shrestha, Ritina ;
Park, Pil-Hoon ;
Lee, Eung-Seok .
BIOORGANIC CHEMISTRY, 2019, 87 :495-505
[9]   Synthesis of α-Trifluoromethyl Ketones via the Cu-Catalyzed Trifluoromethylation of Silyl Enol Ethers Using an Electrophilic Trifluoromethylating Agent [J].
Li, Lun ;
Chen, Qing-Yun ;
Guo, Yong .
JOURNAL OF ORGANIC CHEMISTRY, 2014, 79 (11) :5145-5152
[10]   Crystal structure of (E)-7-methoxy-2((5-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C18H17NO3 [J].
Luan, Ming-Zhu ;
Meng, Qing-Guo .
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2021, 236 (02) :387-389